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Abstract The capacity of mesenchymal stem cells
(MSCs) to differentiate into intervertebral disc (IVD)-like
cells has been well described, but their ability to modulate
the inflammatory processes in the IVD remains unclear.
We found that tissue obtained by discectomy of degener-
ated and post-traumatic IVD contains significant amounts
of IgG antibodies, a sign of lymphocyte infiltration. Further
we investigated whether MSCs in vitro, which were char-
acterized for their multilineage differentiation potential and
may have immunomodulatory effects on IVD fragments.
IVD fragments were co-cultured in contact with peripheral
blood lymphocytes (PBLs) and MSCs, and as functional
controls we used contact co-cultures of PBLs stimulated
with pokeweed mitogen (2.5 lg/mL) and MSCs. The time
course of lymphocyte proliferation (Alamar Blue), IgG
(ELISA) and gene expression (RT-PCR) of anti-inflam-
matory cytokines (TGF-b1, IL-10) by MSCs and pro-
inflammatory molecules (IL-1a, IL-1b and TNF-a) by the
IVD fragments were analyzed. Depending on the response
to the presence of MSCs, the IVD fragments (n = 13) were
divided in two groups: responders (n = 9), where inflam-
mation was inhibited by MSCs and non-responders
(n = 4), where MSCs did not decrease inflammation. At
1 week in co-culture, MSCs reduced significantly the IgG
production in the IVD responders group to 69% and PBLs
proliferation to 57% of the control. MSCs expression of
the anti-inflammatory TGF-b1 increased with time, while
IL-10 was expressed only at day 1. IVD gene expression
of TNF-a decreased constantly, whereas IL-1a and IL-1b
expression increased. In conclusion, these data suggest that
MSCs may modulate disc-specific inflammatory and pain
status and aid regeneration of the host tissue.
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Introduction
Chronic back pain is a common disorder which has been
associated with degeneration of the intervertebral disc
(IVD) [1]. The IVDs structure is finely regulated and
failure in balancing the processes of matrix formation and
degradation leads to degeneration of the tissue. During
degeneration, the cell loss [2] and decrease in proteoglycan
content lead to [3] progressive loss of space between ver-
tebrae and instability, which triggers other events, such as
and nerve and vessel ingrowth [4, 5]. The local production
of matrix-degrading enzymes is a key event leading to
degeneration, but it must be also considered in the context
of the upstream molecules, such as cytokines, which
regulate enzyme synthesis. IVD cells have a capacity
to express a range of cytokines [6, 7], including pro-
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inflammatory molecules, such as both isoforms of inter-
leukin-1, alpha (IL-1a) and beta (IL-1b) [8] and tumor
necrosis factor alpha (TNF-a) [9]. It has been proposed that
IL-1 can regulate IVD cell expression of key matrix-
degrading enzymes in vitro [10] and in vivo [11], placing
this cytokine as a main factor inducing degeneration.
In the healthy IVD, the expression of IL-1 is matched by
its natural inhibitor IL-1Ra, but during degeneration IL-1a
and Il-1b gene expression is upregulated, disrupting the
balance with the inhibitor [8]. TNF-a is widely expressed
in normal and degenerated IVDs, but data about this gene
are controversial. Seguin et al. [12] described that, in
bovine nucleus pulposus cells, TNF-a reduced synthesis of
extracellular matrix and increased expression of matrix-
degrading enzymes, while later Le Maitre et al. [13]
showed that TNF-a had no impact on human matrix
degrading activity and also found that native IVD cells
expressed low levels of TNF-a receptor, which were fur-
ther decreased during degeneration. Thus, TNF-a produced
by IVD cells may have a pro-inflammatory effect either on
the surrounding tissues (muscles, bones or nerves) or on
lymphocytes which infiltrated the IVD tissue during trau-
matic or degenerative disruption of the vertebral end plates.
These events can lead to swelling, acute and chronic dis-
cogenic pain, symptoms that currently are treated either
conservatively with steroid and non-steroid anti-inflam-
matory drugs or surgically. Both approaches have their
limitations, including various side effects and above all,
treating the symptoms and not the underlying process of
degeneration.
Recently, much attention has been given to the potential
use of stem cells in regenerative treatment of the IVD.
Mesenchymal stem cells (MSCs), characterized by their
relatively easy availability, their capacity to proliferate
rapidly and differentiate in vitro and in vivo, have been
frequently associated with tissue engineering and cell-
based therapies aimed to replace damaged tissues. MSCs
have been used to repair injured tissue and to replace
necrotic and apoptotic cells in many animal models of
human diseases [14]. Despite the MSCs’ ability to differ-
entiate both in vitro and in vivo, it has been shown that in
the majority of cases, the observed improvements were not
a clear result of the engraftments [15]. In one of the first
human trials of MSC implantation [16], children affected
by osteogenesis imperfecta had bone marrow transplanta-
tion and, after several years, they received MSCs from the
same donor. The procedure resulted in substantial
improvements, however, the amount derived from the
donor cells detected in bone, skin and other tissue was
equal just to 1%. Another example is that of a murine
model for myocardial infarction, where intravenous
administration of MSCs improved cardiac function after
3 weeks but only a few MSCs were detectable in the
cardiac muscle [17]. Therefore, it is clear that MSCs do not
repair damaged tissue only by differentiating, but also by
interacting with the surrounding tissue via other mecha-
nisms. For example, Nasef et al. demonstrated that, in cell
contact co-culture of human MSCs and T lymphocytes, T
cell proliferation is inhibited by the presence of MSCs [18].
Indeed, the immunomodulatory (regulating the level of an
immune response) properties of MSCs by secreting cyto-
kines were established in vitro [14] and in vivo [19] and
also work has been done to clarify that they suppress
the allogenic response of mixed lymphocyte reaction
[20–22] and modify antigen-presenting cells maturation in
vivo [23].
The objective of our study was to evaluate the immu-
nosuppressive influences of MSCs in vitro on IVD frag-
ments obtained from patients undergoing discectomy. We
discovered that post-traumatic and degenerated discs con-
tained significant amounts of IgG, probably produced by
lymphocytes infiltrating during the breakdown of the end
plates. We were further interested to investigate if MSCs in
vitro can reduce the production antibodies, pro-inflamma-
tory cytokines by the disc tissue and if, in a co-culture with
disc fragments, the MSCs would be induced to express
anti-inflammatory genes, such as transforming growth
factor—beta 1 (TGF-b1) and interleukin-10 (IL-10) [18].
In addition, lymphocyte blastogenic transformation (lym-
phocyte proliferation) was measured as a primary immune
reaction indicator.
Materials and methods
Isolation of MSCs from adult human bone marrow
Bone marrow was obtained from the iliac crest of the
donors during surgery after informed consent by a proce-
dure approved by the ethics committee of canton Luzern.
Bone marrow aspirates (three donors, average age
48 years) were diluted in 3.8% sodium citrate and
19 phosphate buffered saline (PBS) and filtered through a
100-lm cell strainer (Falcon, BD Bioscience). Mononu-
clear cells were separated by Ficoll gradient centrifugation
(density 1.077 g/mL; GE Healthcare) in a Leucosep tube
(Greiner) at 800 g for 20 min. Cells were washed once
with PBS, centrifuged again, re-suspended in 10 mL PBS
and counted using trypan blue dye in a Neubauer chamber
(C-Chip Typ Neubauer, Zeiss). Cells were placed in a T150
tissue culture flask (TPP) in NH-expansion medium
(Miltenyi) at 37C in a humid atmosphere containing 5%
CO2. After 2 days, non-adherent cells were discarded,
whereas adherent cells were cultured in DMEM/
F12 ? GlutaMAX, supplemented with 10% fetal bovine
serum (FBS) (100 units/mL) penicillin/(100 mg/mL)
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streptomycin, 2.5 ng/mL amphotericin B (all GIBCO) and
5 ng/mL recombinant bFGF (Peprotech) at 37C in a
humid atmosphere containing 5% CO2, with medium
changed three times a week. At 70% confluence, cells were
harvested by dissociation with 0.05% trypsin and expanded
to another passage. MSCs were cryopreserved at -150C
in a medium containing 45% DMEM/F12, 45% FBS and
10% dimethyl sulfoxide (DMSO).
MSCs in vitro characterization and differentiation
into osteogenic, chondrogenic and adipogenic
phenotype
Mesenchymal stem cells were characterized by colony
forming unit (CFU) assay, cellular morphology and
immunostaining with mesenchymal stem cell markers
CD105 and Stro-1. CFU assay was achieved by seeding
cells at 1 9 102/dish in 10-cm dishes (FALCON, PRI-
MARIA Tissue Culture Dish) in DMEM/F12 containing
10% FBS (100 units/mL) penicillin/(100 mg/mL) strepto-
mycin, 2.5 ng/mL amphotericin B and 10 ng/mL basic
fibroblast growth factor (Peprotech) for 2 weeks.
Cells were stained with antibodies for cell surface
epitopes CD105 (SH2 or endoglin) [24] and Stro-1, both
mesenchymal stem cell markers. Cells were incubated
for 1 h with the monoclonal mouse antibodies (1:10
dilution, P3D1, Developmental Studies Hybridoma
Bank) followed by fluorescein isothiocyanate (FITC)-
conjugated antimouse IgG secondary antibody (1:15
dilution, Bethyl).
The potential of MSCs to differentiate into chondro-
genic, osteogenic and adipogenic lineage was investigated
to characterize cell populations (n = 3). Cells in mono-
layer were plated at 5 9 105 cells/cm2 for the adipogenic
and chondrogenic differentiation, and 5 9 103 cells/cm2
for the osteogenic differentiation, in distinct six-well cul-
ture plates. Cultures were then stimulated with the appro-
priate differentiation medium according to the conditions
described below. As negative control, cells were grown in
basal medium: DMEM/F12, 5% FBS (100 units/mL) peni-
cillin/(100 mg/mL) streptomycin and 2.5 ng/mL ampho-
tericin B.
Chondrogenic differentiation
Cells were stimulated for 4 weeks in basal medium sup-
plemented with 40 ng/mL dexamethasone, 50 mg/mL
L-proline, 50 mg/mL L-ascorbic acid 2-phosphate (all Sigma-
Aldrich), 19 insulin–transferrin–selenium (Gibco) and
5 ng/mL human recombinant TGF-b1 (Peprotech). Prote-
oglycans (glycosaminoglycans) were stained with Alcian
Blue (Sigma-Aldrich). Aggrecan gene expression was
determined as chondrogenesis marker.
Osteogenic differentiation
Cells were stimulated for 2 weeks in basal medium supple-
mented with 0.05 mM L-ascorbic acid 2-phosphate, 10 mM
b-glycerophosphate (Sigma-Aldrich) and 100 nM dexa-
methasone. Von Kossa stain was used to identify minerali-
zation in the cell culture: under light illumination, silver
phosphate was degraded to silver (black stain). Osteopontin
gene expression was determined as osteogenesis marker.
Adipogenic differentiation
Cells were cultured for 3 weeks under two different culture
conditions: adipogenesis inducing medium—basal medium
supplemented with 1 lM dexamethasone, 0.5 mM 3-iso-
butyl-1-methylxanthine, 0.5 mM indomethacin and 170 mM
insulin (all Sigma-Aldrich); and adipogenesis maintenance
medium—basal medium supplemented with 170 mM insu-
lin. Lipid droplets were revealed by staining with Oil Red O
(Sigma-Aldrich). Leptin gene expression was determined as
adipogenic marker.
Intervertebral disc fragments harvest
Following informed consent, 13 human intervertebral disc
(IVD) samples were obtained from 8 donors who underwent
disc surgery (Table 1). Harvested IVD fragments were
washed twice in PBS and cultured in DMEM/F12 ? Gluta-
MAX, supplemented with 10% FBS (100 units/mL) penicil-
lin/(100 mg/mL) streptomycin and 2.5 ng/mL amphotericin
B. Fragments were cut manually to sections with the same size
and co-cultured with MSCs and PBLs. Separate parts from the
same disc fragment were distributed to both control and
treated sample groups.
Separation of peripheral blood lymphocytes
Human peripheral blood lymphocytes (n = 13) (PBLs)
were obtained from healthy volunteers (average age
35 years), one donation for each experiment. PBLs were
isolated from 15 mL peripheral blood by centrifugation at
800 g for 20 min on a Ficoll gradient (density 1.077 g/mL;
GE Healthcare) in a Leucosep tube (Greiner). Cells were
washed once with PBS, counted using trypan blue dye in a
Neubauer chamber (C-Chip Typ Neubauer, Zeiss) and used
immediately in co-culture.
MSCs, PBLs and IVD fragments co-culture
Triplicates of MSCs and PBLs were co-cultured in contact in
a 96-well plate (TPP) at the ratio of 1–10 in 200 lL of
RPMI ? GlutaMAX, supplemented with 10% FBS
(100 units/mL) penicillin/(100 mg/mL) streptomycin and
594 Eur Spine J (2011) 20:592–603
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2.5 ng/mL amphotericin B at 37C in a humid atmosphere
containing 5% CO2. MSCs were cultured at the density of
2 9 105 cells/well. As a positive control, PBLs activated by
2.5 lg/mL pokeweed mitogen (lectin from Phytolacca
americana, Sigma-Aldrich) were used, and the negative
control was untreated PBLs. Because different fragments
from the same sample may not be equivalent, to avoid inter-
fragment bias, IVD fragment triplicates were derived from
three separate fragments, cut into three cubes (approx. 3 9 3
9 3 mm size), one cube for each test group. IVD fragments
were co-cultured with non-activated PBL, with or without
MSCs; as a reference, disc fragments were cultured alone.
Alamar Blue proliferation assay
Alamar Blue (LucernaChem) at a concentration of 10%
was added to the cell culture medium of each PBL sample.
The cell suspension culture of PBL and the Alamar Blue
were mixed in a new 96-well plate to exclude MSCs from
the assay. After 4 h of incubation at 37C, fluorescence
was measured (kex = 535 and kem = 595 nm) using a
multiwall plate fluorimeter (DTX 880-Multimode detector,
Beckman-Coulter). The gradient of defined cell concen-
trations served as a reference, and assays were run in
triplicate for each sample.
IgG quantification by ELISA
Polystyrene plates (96-well, Beckman-Coulter) were
coated with 1 lg/mL Protein A (Zymed, Lubio Science)
diluted in PBS and incubated overnight at 4C. Plates were
washed three times by an automated plate washer
(Beckman-Coulter) with PBS, followed by blocking of the
additional binding sites in the wells by incubating for 1 h
with 5% Top Block in PBS (Lubio Science).
Culture media containing IgG was collected from every
cell culture and IVD fragment culture sample and then
incubated for 2 h in the protein A-coated plates in triplicate
for each sample. Goat antihuman IgG horseradish peroxidase
(HRP)-conjugated secondary antibodies (Bethyl) were added
to each well at the dilution of 1:5,000 in 5% Top Block ? 5%
FBS and incubated for 1 h at room temperature. Dilutions of
purified human IgG (Zymed) were used as standards.
Citrate buffer, pH 5, containing the HRP substrate
O-phenylenediamide (Zymed) and 0.3% H202, was added
in each well, and after approximately 10 s the enzyme
reaction was stopped by adding 0.1 M H2SO4. The optical
density [25] at 450 nm was read by a plate reader (DTX
880, Multimode detector, Beckman-Coulter). The raw data
were normalized to a standard curve and used for calcu-
lation of total human IgG.
RNA isolation, cDNA synthesis and real-time PCR
Total mRNA was isolated using TriFast RNA isolation
reagent (PeqLAB) according to the manufacturer’s
instructions with modifications. In brief, 200 lL chloro-
form (AppliChem) was added for 1 mL of TriFast to each
sample, and sample tubes were centrifuged at 10,000 rpm
for 10 min to enable phase separation. The aqueous phase
was transferred to a new tube and 750 lL of isopropanol
and 2 lL polyacryl carrier (Molecular Research Center,
Inc.) was added to aid precipitation of RNA, centrifuged at
14,000 rpm for 10 min and RNA pellets were washed in
Table 1 Demographic details of donors
Sample Sex Donar age
(years)
Type of
sample
Initial IgG
content (ng/mL)
CD45
RNA
Thompson
grading scale
Type of operation
1 M 25 AF 7 - IV DDD L5/S1. Stabilization and decompression
2 M 25 NP 30 ? IV DDD L5/S1. Stabilization and decompression
3* F 70 AF 14 ? II Trauma. Th12/L1 ventral spondylodesis
4 F 70 NP 20 ? II Trauma. Th12/L1 ventral spondylodesis
5* M 37 MD 646 ? V DDD Discectomy L5/S1
6 M 55 MD 63 - IV DDD. Spondylodesis. C3/4
7* F 39 AF 14 ? II Trauma. Stenosis. Vertebrectomy C4/5
8 F 39 NP 30 ? II Trauma. Stenosis. Vertebrectomy C4/5
9 F 41 AF 6 ? V DDD. Decompression L3/4
10* F 41 NP 24 ? V DDD. Decompression L3/4
11 M 44 MD 727 ? IV DDD. Microdiscectomy L5/S1
12 M 29 AF 811 - III Trauma. L1/L2
13 M 29 NP 3036 ? III Trauma. Th12/L1
AF annulus fibrosus, NP nucleus pulposus, DDD degenerative disc disease
* Not responding samples
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70% ethanol, dried and re-suspended in RNAse-free water.
Total RNA was stored at -80C.
The collected IVD fragments were frozen at -80C and
pulverized with a stainless steel mortar and pestle, kept on
dry ice. Finally, the IVD fragment powder was dissolved in
1 mL of TriFast, and RNA was isolated as described above.
cDNA was prepared from total RNA using VILO cDNA
Synthesis Kit (Invitrogen). RNA (B500 ng) was used for
cDNA synthesis in a reaction volume of 20 lL. cDNA was
diluted 1:10 with RNAse-free water and stored at -20C.
For real-time (RT)-PCR, DNA template (5 lL) was
mixed with the PCR reaction solution (IQ SYBR Green
Supermix, Bio Rad). The analyzed genes were CD45,
GAPDH, IL-1a, IL-1b, leptin, osteopontin, TNF-a, TGF-
b1 and IL-10. Primers, listed in Table 2, were used at a
concentration of 0.25 nL in PCR reactions, carried out in
triplicates in a final volume of 25 lL in 96-well low profile
PCR polypropylene plates (Bio Rad). To check the speci-
ficity of the amplification products, a melting curve ana-
lysis was carried out after each reaction.
MSCs modulation of IVD fragments
To further understand the influence of MSCs on IVD, we
co-cultured MSCs (2 donors, average age 43 years) and
IVD fragments (2 donors, average age 44 years) in contact
for 14 days in the absence of peripheral blood lympho-
cytes. MSCs were plated at two densities: 10,000 cells/well
(2,780 cells/cm2) and 50,000 cells/well (13,904 cells/cm2)
in a 12-well plate. Media from samples were collected after
7 and 14 days of co-culture and IgG production was
evaluated. IVD fragments without MSCs were considered
as reference.
Statistical analysis
To compare gene expression, IgG quantification and cell
proliferation were used non-parametric Mann–Whitney–
Wilcoxon U test for dependent variables, because ANOVA
would assume normal distribution of the data, which can-
not be guaranteed in this data set. Values are reported as
mean ± SD. A significance value of p \ 0.05 was speci-
fied. Data analysis was performed with SPSS for Windows
14.0 (SPSS Inc.).
Results
MSCs characterization and differentiation
The bone marrow extracted MSCs were initially charac-
terized by the ability to create colony forming units (CFU),
by their characteristic elongated fibroblastic cellular mor-
phology and by immunostaining with mesenchymal stem
cell marker CD105 (Fig. 1a–c) and Stro-1 (data not
shown). Further, MSCs were also histologically tested for
their ability to differentiate chondrogenic (Fig. 1d, e),
adipogenic (Fig. 1g, h) and osteogenic (Fig. 1j, k)
Table 2 Human marker genes
used in quantitative RT-PCR
(F forward, R reverse)
Gene Primer nucleotide sequence (50–30) Product size (bp)
Aggrecan F—AGGCTATGAGCAGTGTGACG 125
R—GCACGCCATAGGTCCTGA
CD45 F—CAGTTTCCCCCATTGACAACC 120
R—CAGAGGCATTAAGGTAGGCATC
GAPDH F—TGGACTCCACGACGTACTCA 102
R—GGAAGCTTGTCATCAATGGAA
IL-1a F—AACCAGTGCTGCTGAAGGA 97
R—TTCTTAGTGCCGTGAGTTTCC
IL-1b F—CTGTCCTGCGTGTTGAAAGA 70
R—TTGGGTAATTTTTGGGATCTACA
IL-10 F—GATGCCTTCAGCAGAGTGAA 105
R—GCAACCCAGGTAACCCTTAAA
Leptin F—TTGTCACCAGGATCAATGACA 71
R—GTCCAAACCGGTGACTTTCT
Osteopontin F—GAGGGCTTGGTTGTCAGC 129
R—CAATTCTCATGGTAGTGAGTTTTCC
TNF-a F—CAGCCTCTTCTCCTTCCTGAT 123
R—GCCAGAGGGCTGATTAGAGA
TGF-b1 F—TGGAGACAGGGGCTTTTATTT 121
R—CTCCAGCCTCCTTAGATCACA
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phenotypes, colored, respectively, by Alcian Blue, Oil Red
O and von Kossa staining. The induced differentiation was
further confirmed by gene expression of specific markers
by RT-PCR analysis of aggrecan (chondrogenesis), leptin
(adipogenesis) and osteopontin (osteogenesis) (Fig. 1f, i, l).
MSCs elicit different immunomodulation
depending on IVD source
Human IVD fragments (n = 13) were co-cultured in con-
tact with PBLs or PBLs and MSCs for 1 week. As a control
of the inducibility of the lymphocytes, PBLs stimulated by
pokeweed mitogen (PBLs ? PWD) were used and the
immunomodulation properties of the MSCs were con-
trolled by the stimulated PBLs, co-cultured with MSCs
(PBLs ? PWD/MSC). Lymphocytes blasts transformation
reactions were observed microscopically in the positive
control samples (PBL ? PWD) at days 3 and 7 (Fig. 2),
but blasts diminished significantly when MSCs were
present in the co-culture. IVD fragments co-cultured with
lymphocytes lead to identical blast morphology at day 7
and again, MSCs in co-culture reduced the intensity of the
blastogenic transformation.
Depending on the effects of MSCs on IgG production
after 1 week of co-culture with PBLs, IVD were divided in
two groups: responders and non-responders (Fig. 3a).
Approximately, 70% of the tested IVD samples (n = 9),
the responders group, decreased their production of IgG in
contact PBLs by more than one-third upon co-culture with
MSCs. In contrast, the remaining 30% (n = 4), non-
responders, did not show any reaction to co-culture, neither
stimulated PBLs, nor were influenced by MSCs (data
not shown). We further focused our attention on the
group responding to MSCs immunomodulation (n = 9).
Fig. 1 Characterization and
differentiation of MSCs in vitro.
MSCs were characterized by
colony forming units (CFU)
ability (a), morphology (b) and
by immunostaining with
antibodies against CD105 (c).
MSCs were differentiated in
chondrogenic phenotype and
stained by Alcian Blue,
counterstained with nuclear fast
red (d, e), adipogenic phenotype
was stained by Oil Red O
(g, h fat-containing vacuoles
magnification in the inset),
while osteogenesis was revealed
by Von Kossa staining (j, k).
Differentiation was confirmed
by gene expression analysis of
respective differentiation
markers: aggrecan
(chondrogenic, Fig. 1f), leptin
(adipogenic, Fig. 1i) and
osteopontin (osteogenic,
Fig. 1l). Data are represented as
fold increase normalized to
negative control (entire scale
bar 125 lm)
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IgG production in co-culture with IVD fragments was
characterized by a large inter-sample variability among
different donors (Fig. 3b). IVD fragments in co-culture
with PBL increased in average 2.4-fold the production of
IgG when compared with disc fragments alone, while in the
presence of MSCs in the same co-culture, the increase
corresponded just to 1.5, demonstrating the repressive
action of MSCs.
It was shown that the effect of pokeweed mitogen on
IgG production by PBLs has completely different kinetics
when compared with the effect of IVD fragments on IgG
production. From days 1–3, PBLs stimulated with PWD
did not synthesize significantly different amounts of IgG
from the untreated control (no PWD), but after 1 week,
there was dramatic increase in IgG (p \ 0.05, Fig. 3c)
corresponding to the expected time used by lymphocytes to
synthesize IgG. On the other hand, when compared with
IVD cultured alone, the production of IgG in the IVD and
PBLs co-culture was increased to 180% when compared
with negative control during days 1 and 3, while after
1 week, IgG detected in the medium was 235%. After
1 week, the presence of MSCs in co-cultures significantly
reduced the production of IgG by PBLs stimulated by
PWD and IVD. There, pokeweed mitogen activated PBLs
reduced the synthesis of IgG by 83% (p \ 0.05) and IVD
induced PBLs reduced IgG by 31% (p \ 0.05) (Fig. 3d).
During days 1 and 3, MSCs did not affect the IgG amount
in both co-cultures of IVD and PBLs, and stimulated PBLs.
MSCs reduced significantly PBLs proliferation
in IVD co-cultures
Mesenchymal stem cells presence in co-culture significantly
inhibited the proliferative response of PBLs to PWD and IVD
fragments, as measured by Alamar Blue metabolic activity
assay (Fig. 4a). Over the time course of the experiments,
PWD stimulated PBLs proliferation to 150% during the first
3 days and to 177% after 1 week. Co-culture with IVD
fragments did not affect PBL proliferation, except at day 1
with an increment in proliferation of 111%. Both PBLs and
IVD data were normalized to PBLs cultured without PWD.
The addition of MSCs to cultures significantly inhibited
the proliferation of PWD and IVD stimulated PBLs after
1 week (Fig. 4b). At the first day of co-culture, MSCs
might have influenced slightly the proliferation of stimu-
lated PBLs—a reduction by only 6% when compared with
Fig. 2 Microphotographs of
lymphocyte blast stimulation in
PBLs culture, PBLs ? PWD
and PBLs ? PWD/MSCs.
Pictures were taken after 1, 3
and 7 days of co-culture. On the
bottom, photos of IVD
fragments cultured alone, with
PBLs and with PBLs/MSCs
after 1 week of co-culture
(entire scale bar 250 lm. PBLs
peripheral blood leukocytes,
MSCs mesenchymal stem cells,
PWD pokeweed, IVD
intervertebral disc)
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PBLs ? PWD. However, the effect of MSCs after 3 days
was clearly visible, reducing proliferation with 48%
(p \ 0.05) and after 1 week, proliferation was further
reduced by 60% (p \ 0.05). In contrast, PBLs co-cultured
with IVD tissue and MSCs initially were stimulated by the
MSCs to proliferate, and increased by 37% at day 1 when
compared with PBLs in co-culture with IVD (set as 100%)
and by 18% after 3 days of co-culture. However, this was a
trend of a constant decrease and after 1 week in co-culture
with MSCs and IVD, PBL proliferation was reduced by
43% when compared with the control (p \ 0.05).
Expression of pro-inflammatory cytokine genes
by PBLs
We further analyzed the gene expression of three cytokines
typically involved in sustaining the inflammatory state,
namely IL-1a, IL-1b and TNF-a. Quantitative real-time
PCR was used to compare the effect on gene expression in
PWD stimulated PBL (Fig. 5a) and IVD fragments
(Fig. 5b) after co-culture with MSCs and PBL. Data were
normalized to positive controls from the same day: PWD
stimulated PBL and IVD fragments in co-culture with PBL,
respectively. The presence of MSCs decreased the
expression of these pro-inflammatory genes stimulated by
PWD only at day 1, whereas during the time course of the
experiment the expression, level of these genes increased
constantly. Finally, gene expression levels of IL-1a, IL-1b
and TNF-a were, respectively, increased significantly to
17, 21.4 and 56-fold increase when compared with the
positive control at day 7 (p \ 0.05). In contrast, MSCs
induced the gene expression of IL-1a, IL-1b and TNF-a in
the IVD fragment samples at day 1 to 137–149%, however,
the trend for the separate genes throughout the duration of
experiment was different for each. TNF-a gene expression
was progressively decreasing, and after 1 week, the
expression was reduced to 0.53 of the control (p \ 0.05).
The IL-1a gene expression went down to 0.98% at day 3,
but up to 2.1-fold after 1 week. On the other hand, the
pattern of expression of IL-1b was undoubtedly increasing
during the time line of the experiments, and by week 1
reached 2.85-fold increases when compared with positive
control.
Expression of anti-inflammatory cytokine genes
by MSCs
Gene expression of TGF-b1 and IL-10, cytokines involved
in anti-inflammatory processes, was measured in the
MSCs, which were in co-cultures with PWD stimulated
Fig. 3 IgG production by PBLs in direct co-culture with IVD and
MSCs. After 7 days, 70% of IVD analyzed responded to IVD
stimulation and MSC immunosuppressive action (a) (data normalized
to disc alone). IVD and PBLs co-culture produced unequal increase in
IgG production among different samples (individual samples depicted
by a line). The addition of MSCs in co-cultures reduced this increase
by more than one-third on an average (b). IgG production by PBLs
stimulated by PWD and in co-culture with IVD. Only after 7 days,
IgG production was strongly stimulated by PWD (32-fold increase
when compared with day 1) (c), IVD immediately doubled the IgG
production by PBLs (data normalized to negative control of the
respective day). After 7 days, MSCs reduced by 83% and by 31% the
IgG production by PWD and, respectively, IVD stimulated PBLs
(d) (data normalized to positive control of the respective day;
represented as a mean ± SD, *p \ 0.05; when compared with day 1)
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PBLs or IVD fragments. The expression of TGF-b1 gene in
MSCs decreased slightly on day 1 for both co-cultures
when compared with day 0, but the pattern of expression of
TGF-b1 switched later to up-regulation, which reached
5.58-fold increase for PBLs co-culture (p \ 0.05) and 1.3-
fold increase for IVD co-culture at day 7 (Fig. 6a).
Although IL-10 is not expressed usually by MSCs in
monolayer cultures, IL-10 gene expression was detectable
at day 1 in both co-cultures (Fig. 6b).
MSCs modulation of IgG secretion by IVD fragments
In contrast to the results obtained with co-cultures with
PBLs, after 7 days, MSCs stimulated IVD secretion of IgG
(133% increment at MSCs density of 10,000 cell/well and
163% at density of 50,000 cells/well) (Fig. 7). However, at
day 14, the stimulation of IgG MSCs was replaced by the
opposite effect after 14 days, and MSCs suppressed IgG
secretion. IgG levels in the media were lower at MSCs
density of 10,000 cell/well (72% reduction relative to
control, p \ 0.05) when compared with density of
50,000 cells/well (32% reduction, p \ 0.05).
Discussion
We do not know why some people with disc degeneration
have pain and some are pain free, but one of the possible
explanations is the development of intradiscal inflamma-
tion. Previous studies have demonstrated that a variety of
inflammatory mediators have been implicated in the
degeneration of the IVD and discogenic pain, including
nitric oxide [26], interleukins, matrix metalloproteinases,
prostaglandin E2 [27] and a group of cytokines [13]. The
analysis conducted showed that the IVD responses to such
pro-inflammatory mediators are not always consistent and
such pro-inflammatory molecules, if present in the disc
when the integrity of the vertebral endplates is compro-
mised by trauma or degeneration, will attract B lympho-
cytes and antibodies will be produced locally, inside the
disc. Indeed, we observed the presence of significant
amount of IgG antibodies when thoroughly washed
human disc fragments were cultured in vitro (Table 1).
Fig. 4 Alamar Blue assay of the metabolic activity of PBLs
stimulated by PWD and in co-culture with IVD (a). PBLs were
constantly stimulated by PWD (1.5-fold increase when compared
with negative control); while IVD did not significantly promote PBLs
proliferation (data normalized to negative control of the respective
day). In the presence of MSCs, the stimulated PBLs reduced their
proliferation by 0.48 at day 3 and by 0.6 at day 7. PBLs in co-culture
with IVD and MSCs increased their proliferation at day 1 to 1.37, at
day 3 to 1.18, but finally dropped to 0.57 after 1 week (b) (data
normalized to respective positive control, represented as a
mean ± SD; *p \ 0.05 compared with day 1)
Fig. 5 Gene expression of IL-1a, IL-1b and TNF-a by stimulated
PBL (a) and IVD (b), after 1, 3 and 7 days in co-culture with MSCs.
Quantitative RT-PCR analysis (relative expression normalized to
GAPDH and to positive control of the respective day represented as a
mean ± SD, *p \ 0.05 compared with day 1)
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Interestingly, within the same donor, the amount of anti-
bodies detected in NP culture media was always greater
than in the AF culture media. Therefore, we wanted to
investigate if MSCs can lower the inflammation state of
IVD material isolated from patients with disc herniation
(protrusion, extrusion or sequestration), who underwent
full or partial discectomy, when introduced in in vitro co-
culture of human IVD fragments and peripheral blood
lymphocytes. Based on their sensitivity to respond to
MSCs, measured by the reduction of the amount of IgG
produced after 1 week of co-culture, we divided the patient
samples in two groups: responders and non-responders.
70% of the samples, the responders group, had reduction in
IgG production when MSCs were present, while 30% did
not. The experimental setup allowed us to give at least two
possible explanations about the differences between the
groups. First, it is possible that some people are genetically
predisposed to respond to MSCs immunomodulation, while
others are not. However, there were two donors who
donated each separate annulus fibrosus and nucleus pul-
posus disc material, in which cases within the same donor
one of the tissues was sensitive to MSC and the other was
not. In such case, it is likely that the non-responding
samples represent tissues that were not chronically
inflamed and, therefore, were not sensitive to the presence
of MSCs and PBL. However, due to ethical considerations,
this hypothesis is difficult to test. One possible way to
manage this issue in a further planned work is to establish a
more controlled tissue sampling protocol at the operation
theater level, where we can separate among samples taken
directly from a sequester, from disc prolapse or from the
surrounding disc tissues. Co-cultures of the responding
IVD fragments and MSCs showed that inflammation
measured by secreted IgG was reduced significantly after
2 weeks. IgG production by the IVD fragments was
reduced by 75% when compared with control in the pres-
ence of 10,000 MSCs/well. Surprisingly, in the presence of
50,000 MSCs/well IgG inhibition was attenuated when
compared with 10,000 MSCs/well demonstrating that stem
cells are not to be treated as stoichiometric reagents and
showing that MSCs suppressive effects were changing
depending on the type of culture and co-culture proportions
in a non-linear way. In addition, after just 1 week, the
effect of MSCs on IVD (without added PBL) was different
and MSCs promoted IgG production. This result is in
contrast to co-cultures of IVD fragments and PBLs where
already after 1 week, there was a reduction in the inflam-
matory response. An explanation may lie in that the lym-
phocytes which have infiltrated the disc tissue via the
damaged endplate originate from the vertebral body
(detected by the presence of IgG in all IVD samples and
mRNA of the lymphocyte marker CD45, in most of the
samples) and are not phenotypically identical to PBL. The
vertebral body contains hematopoietic bone marrow and
therefore among the infiltrated cells there are immature
leukocytes and such leukocytes are known to be stimulated
into differentiation in the presence of MSC, while PBLs are
not.
Fig. 6 Expression of TGF-b1 and IL-10 genes by MSCs in co-culture
with stimulated PBLs (a) and IVD ? PBLs (b), after 1, 3 and 7 days.
Quantitative RT-PCR analysis (relative expression normalized to
GAPDH compared with day 0, represented as a mean ± SD;
*p \ 0.05 compared with day 1)
Fig. 7 IgG secreted in the media after 1 and 2 weeks in co-culture of
IVD with MSCs, 10,000 MSCs/well and 50,000 MSCs/well (data
normalized to disc alone of the respective day, represented as a
mean ± SD, *p \ 0.05 compared with disc alone)
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To be confident that the stem cells used in the study
were effective immunomodulators, we demonstrated that
MSCs had always an immunomodulatory effect on poke-
weed mitogen stimulated PBL, therefore isolating with
certainty the responding from the non-responding IVD
samples. Consistently after 1 week in co-culture, pokeweed
activated PBLs proliferation decreased in the presence of
MSCs and in 70% of the cases IVD activated proliferation
too. In our experiments, we showed that MSCs had an
effective role in decreasing IgG production in PBLs co-
cultures. After 1 week, the amount of IgG present in the
culture media was reduced by 83% when compared with
positive controls. MSCs also had suppressive effects on
PBLs and IVD co-cultures, reducing IgG production by
31%. The difference was that IVD fragments were not
stimulating PBLs in such a pronounced way and to the
same extent as PWD, hence the reduction was also smaller.
However, such a quantitative comparison between PWD
and IVD as IgG production stimuli makes not much bio-
logical sense, because PWD is an extremely powerful
immunogenic plant-derived lectin, used in the laboratory
practice exactly because of these properties, while IVD is a
‘normal’ tissue.
Interestingly, IVD fragments did not stimulate PBLs
proliferation in co-culture, but in their presence IgG pro-
duction was constantly doubled. This fast doubling of IgG
may correspond to the activation of the already present and
mature infiltrated in the IVD tissue B lymphocytes, while
upon PWD stimulus PBLs produced substantial amounts of
IgG only after 7 days. On the other hand, MSCs were able
to stimulate PBL proliferation at day 1 showing that the
biological effects of MSCs are broad, complex and also
variable in time. Recently, it was demonstrated by
expression profiling arrays that interactions between IVD
cells and adipose-derived MSC are too complex and
involve also change in pro-inflammatory mediators and
targets in the MSC [28]. In conclusion, in our work, MSC
co-culture with IVD fragments promoted a reduction in
PBL proliferation and IgG production, both important
events in inflammation processes, however, the interactions
are complex and the underlying biological processes are
unclear.
In an attempt to understand the underlying inflammation
regulation mechanisms and dynamics, we also investigated
the gene expression of pro-inflammatory cytokines, namely
IL-1a, IL-1b and TNF-a in PBLs and IVD. These mole-
cules were chosen, because their presence was already
described in pathological IVD tissue [13]. When co-cul-
tured with MSCs, PBLs reduced the expression of these
cytokines surprisingly only at day 1. The following days,
the expression was higher than in positive control
demonstrating that MSCs had time limited suppressive
influences on PBLs and after this they reacted in a counter-
intuitive manner. On the other hand, the expression of these
cytokines in the IVD tissue was upregulated at day 1, in the
presence of MSCs in co-culture and the trend after 1 week
differed for each molecule: TNF-a expression decreased,
IL-1a was stabilized and IL-1b increased. The TNF-a
decrease correlated with the reduction in IgG production
and the PBLs’ loss of proliferation, but both isoforms of
IL-1 seem not to be implied in this regulation in a simple
correlation. Unfortunately, we were not able to make a
sound model of what is happening based on this data,
because of the many unknowns, for instance other inter-
leukins, which have not been analyzed here, have been
associated with degenerated disc, such as IL-17 [6] and it is
also known that the interleukins show pleiotropic effects,
i.e. they have different targets in various cells and tissues.
We cannot rule out the possibility that proportion of the
cytokines in the IVD samples come from the disc tissue
instead from the infiltrated leukocytes, as both types of
cells produce interleukins, however, it is clear that the
presence of MSC suppresses inflammation in both cases
and leads to a decrease in IgG (product only of the infil-
trated leukocytes).
We also investigated if MSCs promoted the decrease in
the inflammatory response in co-culture, by expressing
themselves anti-inflammatory molecules, such as IL-10 and
TGF-b1. The expression of these two molecules and
secretion of them in the environment may explain potential
mechanisms by which MSCs are able to reduce the
inflammatory response. The results showed that gene
expression trends were similar when MSCs were co-cul-
tured with pokeweed or IVD stimulated PBLs. The
expression of TGF-b1 was characterized by an initial slight
decrease at day 1—when compared with day 0, but during
the time course of the experiments, the expression was
progressively increasing. On the other hand, IL-10
expression was detectable just at day 1.
The down-regulation of the inflammatory response in
vitro of IVD fragments promoted by MSCs supported the
already published data concerning the immunosuppressive
properties of MSCs in other tissues, including the some-
what intimidating complexity of their modes of action. An
important conclusion, however, is that the potential thera-
peutic application of MSCs for IVD regeneration reaches
beyond the capacity of MSCs to differentiate into disc-like
cells and generate new extracellular matrix. The reduction
of inflammation could be a key element for inhibition of
the activity of the enzymes involved in the process of
tissue degradation, and possibly in pain control. These
data suggest an avenue leading to a possible clinical
application, where autologous, MSCs can be injected in a
painful, but with low level of degeneration IVD, which
may prove an effective substitute to more invasive surgical
interventions.
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